ABVX
Abivax SA
NASDAQ · Healthcare · Biotechnology · FR
$87.49
−0.73%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -1.06x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 1.02x
Liquidity & coverage
- Current ratio
- 5.97x
- Quick ratio
- 5.97x
- Cash ratio
- 5.73x
- Interest coverage
- -17.73x
- EBITDA / interest
- -23.68x
- Working capital
- $399.3M
Cash & dividend
- FCF / debt
- -101.80x
- Cash flow / debt
- -101.71x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026